What if getting a prescription felt as simple and clear as buying your next favorite gadget—without the surprise bills and endless hoops? We take you inside the real shift toward direct-to-consumer healthcare and pharma, where transparent pricing...
rices are leveling, but the real story is where competitive edge is moving: from rebates and discounts to experience, trust, and the moments that keep a patient on therapy. We dig into the MFN pricing model and its ripple effects across U.S. pharma...
Prices that used to hide in the shadows are stepping into the light—and it’s changing how patients get their medicines. We dive deep into the PBM reckoning: why scrutiny is mounting, how California’s new law opens the books on rebates and...
A pharmaceutical giant just pressed the D2C button—and the ripple effects could reset how Americans find, pay for, and receive their medications. We unpack Pfizer’s move to list discounted drugs on TrumpRX, why visible pricing matters to patients...
Policy sparks the shift, but patients feel the impact—faster access, steadier supply, and smarter support. We dig into why major pharma players are pouring billions into U.S. manufacturing, how most favored nation pricing is reshaping reimbursement...
The pharmaceutical landscape is undergoing a seismic shift as the Trump administration drops a bombshell 100% tariff on imported branded and patented drugs, effective October 1st. This game-changing policy mandates that pharmaceutical companies...
Pharmaceutical giants are bringing manufacturing back to American soil in a massive strategic pivot. Eli Lilly’s recent $6.5 billion investment in a Texas facility for its obesity medications signals a transformative shift that’s rapidly...
Curious about where healthcare marketing is heading in the age of AI? Kait Tuson, Founder and CEO of Hello Helio, shares invaluable insights on navigating the complex intersection of technology, regulation, and patient care with Ryan...
Pharmaceutical marketing stands at a critical turning point following the FDA and HHS’s September 2025 coordinated crackdown on direct-to-consumer prescription drug advertising. This watershed moment marks an unprecedented shift in...
The future of pharmaceutical marketing and patient engagement is undergoing a profound transformation. While omnichannel strategies have long been considered the gold standard, promising seamless experiences across all platforms, they’ve often...